Polypeptide active immunosuppressant fraction

Details Polypeptide active immunosuppressant fraction Polypeptide active immunosuppressant fraction

1982-06-30

1984-09-04

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

260112R, 424 88, A61K 3936, A61K 3935, C07G 700

Patent

active

044696779

ABSTRACT:
Immunosuppressive polypeptide fractions prepared by enzymatic digestion of specific allergens are non-reactive in animals and humans and effective by parenteral administration, the immunosuppression being antigen specific, affecting production of immunoglobulins. A method of producing immunosuppressive polypeptide fractions and a method of desensitizing mammals therewith are disclosed.

REFERENCES:
patent: 4158705 (1979-06-01), Malley
Chemical Abstracts, vol. 93, p. 702, Abst. No. 68349w, 1980.
Chemical Abstracts, vol. 91, p. 489, Abst. No. 173156n, 1979.
Chemical Abstracts, vol. 93, p. 477, Abst. No. 184103k, 1980.
King, T. P., Advan. Immunol., vol. 23, p. 77, 84, 87, 88, 89, 91, 93, 1976.

Affiliated with

Also associated with

Rating

Polypeptide active immunosuppressant fraction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide active immunosuppressant fraction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide active immunosuppressant fraction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1891802